ELOX Eloxx Pharmaceuticals
- 0.680
- -0.020-2.86%
Eloxx Pharmaceuticals News
Eloxx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aggarwal Sumit
Eloxx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Androski Lindsay
Eloxx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Rubin Steven D
Eloxx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Walts Alan Edmund
Eloxx Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Roche Finance Ltd(0.1%),Roche Holding Ltd(0.1%)
Eloxx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Eloxx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Eloxx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Eloxx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Eloxx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Eloxx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Eloxx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Eloxx Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Androski Lindsay
Eloxx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Eloxx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Eloxx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Eloxx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Eloxx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Eloxx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Eloxx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Analysis
Price Target
No Data
